King Pharmaceuticals Inc. (NYSE:KG)

12.50

-0.04 (-0.32%)

Mar 16 - Close

Open
12.54
High
12.61
Low
12.43
Vol.
2.56M
Avg. Vol.
3.64M
Mkt Cap
3.10B
52Wk High
13.20
52Wk Low
6.04
Bid
8.14
Ask
8.15
P/E (Trailing)
-6.34
Beta
0.65
Short %
4.70%
Div. Yield
—
Shares
248.47M

Company Profile

King Pharmaceuticals Inc.

King Pharmaceuticals Inc.

501 Fifth Street

Bristol, TN 37620

United States - Map

Phone: (423) 989-8000

Fax: (423) 989-8711

Website: www.kingpharm.com

State of incorporation: Tennessee

CEO: Brian A. Markison

Employees: 3,381

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

A drug-maker.

A pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and and animal health products.

Recent news for KG

Members owning KG also own

HEV (28.57%), XRAY (28.57%), AA (28.57%), ANX (14.29%), ANGO (14.29%)

Member sentiment (?)    Neutral

««     MarketGuru Blog network     »»

Recent opinions on KG

No recent Opinions for KG

Top members owning KG

* Average monthly return vs. S&P 500

- Advertisement -